Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Global Advisory Committee on Vaccine Safety, 9-10 June 2005.

× No keyword cloud information.

12 in total

Review 1. DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster Vaccination.

Authors: Sohita Dhillon
Journal: Drugs Date: 2010-05-28 Impact factor: 9.546

2. Improving global monitoring of vaccine safety: a survey of national centres participating in the WHO Programme for International Drug Monitoring.

Authors: Megan Letourneau; George Wells; Wikke Walop; Philippe Duclos
Journal: Drug Saf Date: 2008 Impact factor: 5.606

Review 3. Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.

Authors: Amy Sarah Ginsburg; Ankita Meghani; Scott B Halstead; Mansour Yaich
Journal: Hum Vaccin Immunother Date: 2017-08-25 Impact factor: 3.452

4. Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: randomized, double-blind, 5-year phase II study in healthy adults.

Authors: Peter E Nasveld; Andrew Ebringer; Nathan Elmes; Sonya Bennett; Sutee Yoksan; John Aaskov; Karen McCarthy; Niranjan Kanesa-thasan; Claude Meric; Mark Reid
Journal: Hum Vaccin Date: 2010-12-01

5. New vaccines for Japanese encephalitis.

Authors: Scott B Halstead; Stephen J Thomas
Journal: Curr Infect Dis Rep Date: 2010-05 Impact factor: 3.725

6. Estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal.

Authors: Shyam Raj Upreti; Kristen B Janusz; W William Schluter; Ram Padarath Bichha; Geeta Shakya; Brad J Biggerstaff; Murari Man Shrestha; Tika Ram Sedai; Marc Fischer; Robert V Gibbons; Sanjaya K Shrestha; Susan L Hills
Journal: Am J Trop Med Hyg Date: 2013-01-28 Impact factor: 2.345

7. Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans.

Authors: Byung-Hak Song; Gil-Nam Yun; Jin-Kyoung Kim; Sang-Im Yun; Young-Min Lee
Journal: J Microbiol Date: 2012-08-25 Impact factor: 3.422

8. The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children.

Authors: Hyo Jin Kwon; Soo Young Lee; Ki Hwan Kim; Dong Soo Kim; Sung Ho Cha; Dae Sun Jo; Jin Han Kang
Journal: J Korean Med Sci Date: 2015-04-15 Impact factor: 2.153

9. A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice.

Authors: Sang-Im Yun; Byung-Hak Song; Jin-Kyoung Kim; Gil-Nam Yun; Eun-Young Lee; Long Li; Richard J Kuhn; Michael G Rossmann; John D Morrey; Young-Min Lee
Journal: PLoS Pathog Date: 2014-07-31 Impact factor: 6.823

Review 10. Japanese encephalitis: the virus and vaccines.

Authors: Sang-Im Yun; Young-Min Lee
Journal: Hum Vaccin Immunother Date: 2013-10-25 Impact factor: 3.452